About the webinar 
The goal of the National Institute of Drug Abuse (NIDA) Clinical Trials Network webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting edge science. In 2021, lectures will include the topics of combined use of opiates and stimulants, the role of stigma in the treatment of addiction, and racial disparities in treatment. 
In this session, John Kelly, PhD, ABPP of Harvard University will discuss the fundamental causes of stigma and discrimination in relation to substance use disorder, review some of the paradoxical findings from the latest stigma research, and suggest how stigma and discrimination might be more systematically addressed to enhance the clinical care and outcomes of individuals suffering from substance use disorder. 

Learning Objectives: 

1.    Discuss two major factors which underlie and contribute to addiction stigma.
2.    Describe three effective strategies for addressing stigma.
3.    Utilize optimal terminology to reduce stigma in various clinical and policy communication scenarios.

1.5 CME or CE credits available: AMA PRA Category 1 Credits; PSY (APA); RN (CA BRN); LMFT, LCSW, LPCC, LEP (CAMFT); RADT I/II, CADC-CAS, CADC I/II, CADC-CS, LAADC (CCAPP); CATC (ACCBC/CAADE); CAODC (CADTP)  
Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers 
(ATTCs) and the Western States Node of the NIDA Clinical Trials Network.